April 2026
The global lip augmentation market size was estimated at USD 8.09 billion in 2025 and is expected to hit around USD 17.07 billion by 2035, growing at a CAGR of 7.75%.
July 2026
The global flip chip market size was evaluated at USD 40.85 billion in 2025 and is projected to surpass around USD 76.18 billion by 2035 with a notable CAGR of 6.43%.
June 2026
The global human high-density lipoprotein (Human HDL) market size is estimated to hit around USD 345.90 billion by 2035 increasing from USD 106.52 billion in 2025, with a CAGR of 12.50%.
May 2026
The global hyperlipidemia drugs market size is calculated at USD 23.85 billion in 2025 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
January 2026
The global cheek augmentation market size was evaluated at USD 2.93 billion in 2025 and is predicted to hit around USD 6.72 billion by 2035, growing at a CAGR of 8.64%.
January 2026
The global lipase testing reagents market size is projected to hit around USD 1,506.31 million by 2035, increasing from USD 742.51 million in 2025, with a solid CAGR of 7.33%.
December 2025
The global body augmentation filler market size is evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 7.38 billion by 2035, growing at a CAGR of 17.91%.
November 2025
The global lecithin and phospholipids market size is estimated to hit around USD 11.92 billion by 2034 increasing from USD 6.76 billion in 2025, with a CAGR of 6.50%.
November 2025
The global alpha-1 antitrypsin deficiency augmentation therapy market size is estimated to hit around USD 2.96 billion by 2034 from USD 1.73 billion in 2025, at a CAGR of 6.14%.
November 2025
The global lipid nanoparticles market size is evaluated at USD 1,142.30 million in 2025 and is expected to attain around USD 3,694.21 million by 2034, with a CAGR of 13.93%.
November 2025
The global pharmaceutical lipid-based excipients market size accounted for USD 2.02 billion in 2025 and is predicted to hit around USD 3.17 billion by 2034, growing at a CAGR of 5.13%.
August 2025
The global liposomal supplements market size was evaluated at USD 349.92 million in 2024 and is predicted to hit around USD 745.02 million by 2034, growing at a CAGR of 7.85%.
August 2025
The global liposome drug delivery market size reached USD 5.59 billion in 2024 and is projected to surpass around USD 13.12 billion by 2034, with a CAGR of 8.91%.
July 2025
The global lipase inhibitors obesity drugs market size was estimated at USD 1.25 billion in 2024 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
July 2025
The global lipid-lowering drugs market size was evaluated at USD 34.27 billion in 2024 and is projected to attain around USD 48.11 billion by 2034 with a CAGR of 3.45%.
July 2025
The global point of care lipid test market size was valued at USD 307.71 million in 2024 and is predicted to attain around USD 472.54 million by 2034 with a CAGR of 4.38%.
June 2025
The global human augmentation market size was valued at USD 376.67 billion in 2024 and is projected to surpass around USD 1,390.01 billion by 2034, with a CAGR of 13.95%.
September 2025
The global LNP CDMO market size was evaluated at USD 205.47 million in 2024 and is predicted to hit around USD 820.46 million by 2034, growing at a CAGR of 14.85%.